The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia (Q43687892)
scientific article published in August 2001
Language:
Current Data About The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia
(P31) (Q13442814)
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

(P304) 1335-1341
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

(P407) (Q1860)

(P433) 8
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

(P478) 24
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

(P577) Wednesday, August 1, 2001
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

(P921) (Q3025883)

(Q66291209)
(P887)

(Q269829)
(P887)

(Q108853737)
(P887)

(P1433) (Q5270111)
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

(P1476) "The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia" (language: en)
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

(P2093) Diabetes Atorvastin Lipid Intervention (DALI) Study Group
(P1545) 1
(P248)
(P698) 11473066
(P813) Saturday, November 25, 2017

other details
description scientific article published in August 2001

External Links
(P356) 10.2337/DIACARE.24.8.1335
(P698) 11473066
(P5875) 279338926
(P8608) release_ihbcoxyv2jc4vfkssyuezhvrwq